BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Bouchet S, Linot C, Ruzic D, et al. (2019) Extending Cross Metathesis To Identify Selective HDAC Inhibitors: Synthesis, Biological Activities, and Modeling. Acs Medicinal Chemistry Letters. 10: 863-868
Roche J. (2018) Erratum: Roche, J. The Epithelial-to-Mesenchymal Transition in Cancer. Cancers, 2018, 10, 52. Cancers. 10
Roche J. (2018) The Epithelial-to-Mesenchymal Transition in Cancer. Cancers. 10
Evanno E, Godet J, Piccirilli N, et al. (2017) Tri-methylation of H3K79 is decreased in TGF-β1-induced epithelial-to-mesenchymal transition in lung cancer. Clinical Epigenetics. 9: 80
Roche J, Gemmill RM, Drabkin HA. (2017) Epigenetic Regulation of the Epithelial to Mesenchymal Transition in Lung Cancer. Cancers. 9
Dimou A, Dincman T, Evanno E, et al. (2017) Epigenetics during EMT in lung cancer: EZH2 as a potential therapeutic target Cancer Treatment and Research. 12: 40-48
Roche J, Nasarre P, Gemmill R, et al. (2016) Erratum: Roche, J. et al. Global Decrease of Histone H3K27 Acetylation in ZEB1-Induced Epithelial to Mesenchymal Transition in Lung Cancer Cells. Cancers, 2013, 5, 334-356. Cancers. 8
Yoshida T, Song L, Bai Y, et al. (2016) ZEB1 Mediates Acquired Resistance to the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer. Plos One. 11: e0147344
Roche J, Nasarre P, Gemmill R, et al. (2013) Global Decrease of Histone H3K27 Acetylation in ZEB1-Induced Epithelial to Mesenchymal Transition in Lung Cancer Cells. Cancers. 5: 334-56
Nasarre P, Gemmill RM, Potiron VA, et al. (2013) Neuropilin-2 Is upregulated in lung cancer cells during TGF-β1-induced epithelial-mesenchymal transition. Cancer Research. 73: 7111-21
See more...